Anthera Pharmaceuticals, Inc. (ANTH) posted fourth-quarter net loss of $8.9 million or $0.11 per share, narrower than $29.2 million or $0.71 per share in the comparable quarter last year.
On average, seven analysts polled by Thomson Reuters expected the company to report a loss of $0.16 per share for the quarter.
Loss from operations narrowed to $8.1 million from $28.2 million in the year-ago quarter.
Total operating expense for the latest fourth quarter declined to $8.1 million from $28.4 million in the prior year period.
For comments and feedback: editorial@rttnews.com